Zhiheng Yu

Beijing, 100049, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

A systematic review and meta-analysis of exposure-response analysis of osimertinib in patients with non-small-cell lung cancer.

A systematic review and meta-analysis of exposure-response analysis of osimertinib in patients with non-small-cell lung cancer.

Journal: European journal of clinical pharmacology

Published: September 16, 2025

Low-dose oral misoprostol vs. oxytocin in premature rupture of membranes at ≥ 36 weeks: a comparison of labor induction outcomes and postpartum hemorrhage risk.

Low-dose oral misoprostol vs. oxytocin in premature rupture of membranes at ≥ 36 weeks: a comparison of labor induction outcomes and postpartum hemorrhage risk.

Journal: BMC pregnancy and childbirth

Published: December 25, 2024

Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic-pharmacodynamic model of uterine contraction frequency.

Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic-pharmacodynamic model of uterine contraction frequency.

Journal: Pharmacotherapy

Published: November 14, 2023

Model-based exploration of the rationality of off-label use of cetirizine in Chinese pediatric patients: a prospective cohort study.

Model-based exploration of the rationality of off-label use of cetirizine in Chinese pediatric patients: a prospective cohort study.

Journal: Frontiers in pharmacology

Published: October 16, 2023

Is there a possibility that P-glycoprotein reduces reproductive toxicity in males but breast cancer resistance protein does not?

Is there a possibility that P-glycoprotein reduces reproductive toxicity in males but breast cancer resistance protein does not?

Journal: Clinical and translational science

Published: August 23, 2023

Dose decision of HSK7653 oral immediate release tablets in specific populations clinical trials based on mechanistic physiologically-based pharmacokinetic model.

Dose decision of HSK7653 oral immediate release tablets in specific populations clinical trials based on mechanistic physiologically-based pharmacokinetic model.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: March 13, 2023

Model-informed drug development: The mechanistic HSK3486 physiologically based pharmacokinetic model informing dose decisions in clinical trials of specific populations.

Model-informed drug development: The mechanistic HSK3486 physiologically based pharmacokinetic model informing dose decisions in clinical trials of specific populations.

Journal: Biopharmaceutics & drug disposition

Published: November 03, 2022

Potential drug-drug interaction of olverembatinib (HQP1351) using physiologically based pharmacokinetic models.

Potential drug-drug interaction of olverembatinib (HQP1351) using physiologically based pharmacokinetic models.

Journal: Frontiers in pharmacology

Published: October 09, 2022

Prediction of pyrotinib exposure based on physiologically-based pharmacokinetic model and endogenous biomarker.

Prediction of pyrotinib exposure based on physiologically-based pharmacokinetic model and endogenous biomarker.

Journal: Frontiers in pharmacology

Published: June 18, 2022

Impact of Dose Reduction of Afatinib Used in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Impact of Dose Reduction of Afatinib Used in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Journal: Frontiers in pharmacology

Published: September 22, 2021

Development of a Virtual Chinese Pediatric Population Physiological Model Targeting Specific Metabolism and Kidney Elimination Pathways.

Development of a Virtual Chinese Pediatric Population Physiological Model Targeting Specific Metabolism and Kidney Elimination Pathways.

Journal: Frontiers in pharmacology

Published: January 01, 2021

Effects of Pharmacist-Led Clinical Pathway/Order Sets on Cancer Patients: A Systematic Review.

Effects of Pharmacist-Led Clinical Pathway/Order Sets on Cancer Patients: A Systematic Review.

Journal: Frontiers in pharmacology

Published: October 15, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026